CorMedix Inc.

About CorMedix Inc.

CorMedix is focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, with a particular emphasis on the prevention of cardiac, renal, and infectious diseases.

Products & Services

DefenCath™ (taurolidine and heparin):A therapeutic product aimed at addressing life-threatening conditions, with specific information available on prescribing and usage.

Specialties

Therapeutic product development Prevention of cardiac diseases Prevention of renal diseases Prevention of infectious diseases Catheter-related bloodstream infections (CRBSIs)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 85000000 MR: - FA: approximately $85 million FAN: 85000000	D: 2025-06-27 FD: 2025-06-27	4 investors
2	RT: Public Offering T: - FT: Public Offering	A: 85000000 MR: - FA: $85.0 million FAN: 85000000	D: 2025-06-26 FD: 2025-06-26	1 investors
3	RT: Public Offering T: - FT: Public Offering	A: 40000000 MR: - FA: $40 million FAN: 40000000	D: 2023-06-28 FD: 2023-06-28	3 investors

Public Offering Latest

2025-06-27

$85.0M

4 investors (Pro only)

Public Offering 2025-06-26

$85.0M

Public Offering 2023-06-28

$40.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Saravanan Balamuthusamy

Nephrologist

N

Nikhil Bhayani

M.D.

T

Teena Chopra

S

Stanley Crittenden

Nephrologist, Chief Medical Officer

A

Aru Narendran

Professor of Pediatrics, Oncology, Biochemistry, and Molecular Biology, Physiology and Pharmacology

K

Kerry LaPlante

PharmD

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

CorMedix Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised